A detailed history of Bartlett & Co. LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 3,466 shares of GILD stock, worth $305,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,466
Previous 4,266 18.75%
Holding current value
$305,285
Previous $320,000 12.19%
% of portfolio
0.0%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$73.27 - $83.09 $58,616 - $66,472
-800 Reduced 18.75%
3,466 $281,000
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $30,832 - $33,639
-417 Reduced 8.9%
4,266 $320,000
Q2 2023

Jul 14, 2023

BUY
$76.01 - $86.7 $72,209 - $82,365
950 Added 25.45%
4,683 $361,000
Q1 2023

Apr 06, 2023

BUY
$77.31 - $88.08 $39,350 - $44,832
509 Added 15.79%
3,733 $307,000
Q3 2022

Oct 17, 2022

SELL
$59.54 - $68.01 $9,705 - $11,085
-163 Reduced 4.81%
3,224 $199,000
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $8,658 - $9,751
150 Added 4.63%
3,387 $209,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $17,376 - $21,774
-300 Reduced 8.48%
3,237 $192,000
Q4 2021

Mar 08, 2022

SELL
$64.88 - $73.64 $129,176 - $146,617
-1,991 Reduced 36.02%
3,537 $257,000
Q3 2021

Oct 15, 2021

SELL
$67.69 - $73.03 $101,535 - $109,545
-1,500 Reduced 21.34%
5,528 $386,000
Q2 2021

Jul 19, 2021

SELL
$63.47 - $69.35 $186,601 - $203,888
-2,940 Reduced 29.49%
7,028 $484,000
Q1 2021

Apr 19, 2021

SELL
$60.0 - $68.46 $122,700 - $140,000
-2,045 Reduced 17.02%
9,968 $644,000
Q4 2020

Jan 20, 2021

SELL
$56.65 - $64.55 $10.1 Million - $11.5 Million
-177,512 Reduced 93.66%
12,013 $700,000
Q3 2020

Oct 20, 2020

SELL
$62.1 - $78.08 $1.45 Million - $1.82 Million
-23,360 Reduced 10.97%
189,525 $12 Million
Q2 2020

Aug 03, 2020

SELL
$72.34 - $84.0 $1.51 Million - $1.75 Million
-20,825 Reduced 8.91%
212,885 $16.4 Million
Q1 2020

May 07, 2020

SELL
$62.63 - $80.22 $2,129 - $2,727
-34 Reduced 0.01%
233,710 $17.5 Million
Q3 2019

Nov 04, 2019

SELL
$62.51 - $69.0 $181,904 - $200,790
-2,910 Reduced 1.23%
233,744 $14.8 Million
Q2 2019

Jul 24, 2019

SELL
$61.87 - $69.38 $314,670 - $352,866
-5,086 Reduced 2.1%
236,654 $16 Million
Q1 2019

Apr 23, 2019

BUY
$62.53 - $70.05 $1.84 Million - $2.06 Million
29,435 Added 13.86%
241,740 $0
Q4 2018

Jan 23, 2019

SELL
$60.54 - $79.0 $4.82 Million - $6.29 Million
-79,563 Reduced 27.26%
212,305 $13.3 Million
Q3 2018

Oct 15, 2018

BUY
$71.28 - $78.92 $855 - $947
12 Added 0.0%
291,868 $22.5 Million
Q2 2018

Jul 31, 2018

SELL
$64.88 - $75.68 $696,292 - $812,197
-10,732 Reduced 3.55%
291,856 $20.7 Million
Q1 2018

Apr 25, 2018

BUY
$72.84 - $88.8 $415,115 - $506,071
5,699 Added 1.92%
302,588 $22.8 Million
Q4 2017

Jan 19, 2018

SELL
$71.15 - $83.52 $369,268 - $433,468
-5,190 Reduced 1.72%
296,889 $21.3 Million
Q3 2017

Oct 23, 2017

BUY
$72.11 - $85.47 $21.8 Million - $25.8 Million
302,079
302,079 $24.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.